ELION THERAPEUTICS EXPANDS PIPELINE WITH EXCLUSIVE GLOBAL LICENSE TO INHALED ANTIFUNGAL FOR IMMUNOCOMPROMISED PATIENTS

Reuters · 3d ago

Please log in to view news